Steven R. Hagen, Senior VP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 3,000 shares at $15.73 ($47K) on 2014-02-27, disclosed to the SEC on 2014-02-27.
Open-market sale of $47k AMRI by Senior VP Pharmaceutical Development & Mfg. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |